The virus that came in from the cold

Science Translational Medicine

Volumn 4, Issue 138, 2012, Pages

  Bell, John C ^a,b  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; NEUTRALIZING ANTIBODY; ONCOLYTIC VIRUS;

ANTINEOPLASTIC ACTIVITY; CANCER GROWTH; CANCER INHIBITION; CANCER LOCALIZATION; CANCER MODEL; CLINICAL EFFECTIVENESS; COLON CANCER; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; HUMAN RHINOVIRUS; MELANOMA; METASTASIS; NONHUMAN; ONCOLYTIC VIROTHERAPY; PRIORITY JOURNAL; SHORT SURVEY; SINGLE DRUG DOSE; SOLID TUMOR; TRANSLATIONAL RESEARCH; TUMOR IMMUNITY; UNSPECIFIED SIDE EFFECT; VIRUS NEUTRALIZATION; VIRUS REPLICATION; ANIMAL; ARTICLE; IMMUNOLOGY; NEOPLASM; VIRUS;

ANIMALS; ANTIBODIES, NEUTRALIZING; HUMANS; NEOPLASMS; ONCOLYTIC VIROTHERAPY; VIRUSES;

EID: 84862580413     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3004139     Document Type: Short Survey

References (10)

1. R. A. Adair, V. Roulstone, K. J. Scott, R. Morgan, G. J. Nuovo, M. Fuller, D. Beirne, E. J. West, V. A. Jennings, A. Rose, J. Kyula, S. Fraser, R. Dave, D. A. Anthoney, A. Merrick, R. Prestwich, A. Aldouri, O. Donnelly, H. Pandha, M. Coffey, P. Selby, R. Vile, G. Toogood, K. Harrington, A. A. Melcher, Cell carriage, delivery, and selective replication of an oncolytic virus in tumor in patients. Sci. Transl. Med. 4, 138ra77 (2012).
2. D. F. Stojdl, B. D. Lichty, B. R. tenOever, J. M. Paterson, A. T. Power, S. Knowles, R. Marius, J. Reynard, L. Poliquin, H. Atkins, E. G. Brown, R. K. Durbin, J. E. Durbin, J. Hiscott, J. C. Bell, VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents. Cancer Cell 4, 263-275 (2003).
3. M. Toda, S. D. Rabkin, H. Kojima, R. L. Martuza, Herpes simplex virus as an in situ cancer vaccine for the induction of specific anti-tumor immunity. Hum. Gene Ther. 10, 385-393 (1999).
4. S. Sivendran, M. Pan, H. L. Kaufman, Y. Saenger, Herpes simplex virus oncolytic vaccine therapy in melanoma. Expert Opin. Biol. Ther. 10, 1145-1153 (2010).
5. C. J. Breitbach, N. S. De Silva, T. J. Falls, U. Aladl, L. Evgin, J. Paterson, Y. Y. Sun, D. G. Roy, J. L. Rintoul, M. Daneshmand, K. Parato, M. M. Stanford, B. D. Lichty, A. Fenster, D. Kirn, H. Atkins, J. C. Bell, Targeting tumor vasculature with an oncolytic virus. Mol. Ther. 19, 886-894 (2011).
6. T. C. Liu, T. Hwang, B. H. Park, J. Bell, D. H. Kirn, The targeted oncolytic poxvirus JX-594 demonstrates antitumoral, antivascular, and anti-HBV activities in patients with hepatocellular carcinoma. Mol. Ther. 16, 1637-1642 (2008).
7. R. M. Lorence, M. S. Roberts, J. D. O'Neil, W. S. Groene, J. A. Miller, S. N. Mueller, M. K. Bamat, Phase 1 clinical experience using intravenous administration of PV701, an oncolytic Newcastle disease virus. Curr. Cancer Drug Targets 7, 157-167 (2007).
8. C. J. Breitbach, J. Burke, D. Jonker, J. Stephenson, A. R. Haas, L. Q. Chow, J. Nieva, T. H. Hwang, A. Moon, R. Patt, A. Pelusio, F. Le Boeuf, J. Burns, L. Evgin, N. De Silva, S. Cvancic, T. Robertson, J. E. Je, Y. S. Lee, K. Parato, J. S. Diallo, A. Fenster, M. Daneshmand, J. C. Bell, D. H. Kirn, Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans. Nature 477, 99-102 (2011).
9. E. J. Ilett, R. J. Prestwich, T. Kottke, F. Errington, J. M. Thompson, K. J. Harrington, H. S. Pandha, M. Coffey, P. J. Selby, R. G. Vile, A. A. Melcher, Dendritic cells and T cells deliver oncolytic reovirus for tumour killing despite pre-existing anti-viral immunity. Gene Ther. 16, 689-699 (2009).
10. R. C. Carlisle, Y. Di, A. M. Cerny, A. F. Sonnen, R. B. Sim, N. K. Green, V. Subr, K. Ulbrich, R. J. Gilbert, K. D. Fisher, R. W. Finberg, L. W. Seymour, Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1. Blood 113, 1909-1918 (2009).